{"id":956009,"date":"2026-04-29T09:05:34","date_gmt":"2026-04-29T13:05:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/"},"modified":"2026-04-29T09:05:34","modified_gmt":"2026-04-29T13:05:34","slug":"codexis-to-share-rna-manufacturing-advances-at-tides-usa","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/","title":{"rendered":"Codexis to share RNA manufacturing advances at TIDES USA"},"content":{"rendered":"<div class=\"mw_release\">\n<p>REDWOOD CITY, Calif., April  29, 2026  (GLOBE NEWSWIRE) &#8212; Codexis, Inc. (NASDAQ: CDXS) a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, will present new data on ECO Synthesis\u00ae Manufacturing Platform and provide an update on regulatory engagement for its enzymatic platform at TIDES USA, held May 11\u201314 at the Hynes Convention Center in Boston.<\/p>\n<p>As RNAi therapies expand into larger indications, manufacturing scalability, maintaining process control and delivering high-quality product is critical. Codexis will present data demonstrating advances in controlling phosphorothioate stereochemistry, improved ligation efficiency and process performance, alongside the sustainability advantages of siRNA manufacturing approaches.<\/p>\n<p>Codexis\u2019 technical experts will present at three sessions during the conference:<\/p>\n<p>\n        <strong>Spotlight Presentation:<\/strong><br \/>\n        <br \/>Controlling Phosphorothioate Stereochemistry: Challenges and Innovations in Oligonucleotide Manufacturing<br \/>Stefan Lutz, PhD., Chief Scientific Officer<br \/>Thursday, May 14, 8:30\u20139:00 a.m.<\/p>\n<p>\n        <strong>TIDES Talk:<\/strong><br \/>\n        <br \/>Superior Ligation Solutions for Scalable RNA Manufacturing<br \/>Derek Gauntlett, Vice President, Development<br \/>Wednesday, May 13, 10:25\u201310:35 a.m.<\/p>\n<p>\n        <strong>Conference Presentation:<\/strong><br \/>\n        <br \/>Advancing Sustainability through Innovation in Oligonucleotide Manufacturing<br \/>David Entwistle, PhD., Senior Director, Program and Pipeline Management<br \/>Wednesday, May 13, 4:15\u20134:45 p.m.<\/p>\n<p>In addition to Codexis\u2019 talks and booth (821) presence at TIDES USA, Codexis will also host an expert panel discussion and networking event, \u201cStereochemistry in RNAi Manufacturing: Signal or Noise?\u201d, on Tuesday, May 12. This panel will explore the growing industry focus on stereochemical control, manufacturing options, and its implications for therapeutic performance, and product quality. Panellists include:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:12pt;margin-bottom:12pt\">John Maraganore, PhD., Founder and Former CEO at Alnylam<\/li>\n<li style=\"margin-top:12pt;margin-bottom:12pt\">Fred Fleitz, PhD., SVP of CMC and Development Chemistry at Arrowhead Pharmaceuticals<\/li>\n<li style=\"margin-top:12pt;margin-bottom:12pt\">Alison Moore, PhD., President and CEO at Codexis<\/li>\n<li style=\"margin-top:12pt;margin-bottom:12pt\">Raman Sehgal, Entrepreneur, and Host of the Molecule to Market Podcast<\/li>\n<\/ul>\n<p>\n        <strong>About Codexis, Inc.<\/strong>\n      <\/p>\n<p>Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, leveraging its proprietary CodeEvolver<sup>\u00ae<\/sup>\u00a0technology platform to discover, develop and enhance novel, high-performance enzymes. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis\u00a0manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis\u2019 unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GibdYY06y-JaB3nsEiWNDhbpfAmM5EFuSXwjcIyaLjaV-dDyPX05FWvNPnZYSgHX1isK13uQolZ0-yRUoEGR7VsGPALoCnMpubNOa9md8nxu6IsQXpzws77WImtsay2zWUsywAAYE--yi2ip8ngdHpNAI8EK8ISQJhXNzpIkm-ZjXF-VG4xXBX-CboSoYO2eVILt0HX44sM94CBLzr7vZqC3YSwcGGm5833r9UNryiqKR4VYrFf0hYcSsKK7gv1Vm6SXlV_JfWFo3vOvnUzueCvrBnowZXRK_guBynGpUuQX82QlDXKbDrjmQ-VgT-w0NDS0APfeMeX-6P512HNX6QJttOdowyUxN0ltaisPqN_s2FOxEoas7mb9O4WVa0wruJ-70IuALXUM0vyXvhu8-VRJjGWZOiiWjGCs_hPjF6BG6qkXwmsOL5qEwD3vUuyOKduKB81kjcRHXH9T_6Pi3R_wFMWi5NmdZdFcLgVmcPM=\" rel=\"nofollow\" target=\"_blank\">codexis.com<\/a>.<\/p>\n<p>\n        <strong>For investor inquiries:<\/strong><br \/>\n        <br \/>Georgia Erbez<br \/>(650) 421-8100<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eCquhiJZO_3KIb-GsGf7qEsD7TZewzZZfxM7vgWNpQrkD6ZRDGoLpvLjyPqyGjksJKK9vxZxlAlDh1mhKurXnjB_u4iueqsOsTsaCi_GCRw0xWvvz3zQQgApVLDRt74zN3BQS50chdt-YmWa9X95WfeZXBcm4j-p1VTID2qwtyM_j4-dcjuq7X2R4d2wB5LAGqok9ZhVKz3YEo2IfSNY9rn2c_RAN3lQJkzMYzQfgAw=\" rel=\"nofollow\" target=\"_blank\">ir@codexis.com<\/a><\/p>\n<p>\n        <strong>For media inquiries:<br \/><\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mI7Dx3IdQQgpmT5xcvUB1sbSsvorgICkIf50it_rVqg3Szg6i7zGiEGOBjHO6wUKKqr5Z1EmszjBl1OR3pxRgwhxus3o4WB6-3FAeGQKmzvxxLYCYJsjTcglRzorLT4A\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <u>aranda@ramarketingpr.com<\/u><br \/>\n        <\/a>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwOTMwMyM3NTcyMzk2IzIwMTY1MzQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTA1NzRkYjUtMmU1Ny00MjFlLTllNTAtMjNkNTY0YTI4NDIzLTEwMjgxMDctMjAyNi0wNC0yOS1lbg==\/tiny\/Codexis-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) &#8212; Codexis, Inc. (NASDAQ: CDXS) a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, will present new data on ECO Synthesis\u00ae Manufacturing Platform and provide an update on regulatory engagement for its enzymatic platform at TIDES USA, held May 11\u201314 at the Hynes Convention Center in Boston. As RNAi therapies expand into larger indications, manufacturing scalability, maintaining process control and delivering high-quality product is critical. Codexis will present data demonstrating advances in controlling phosphorothioate stereochemistry, improved ligation efficiency and process performance, alongside the sustainability advantages of siRNA manufacturing approaches. Codexis\u2019 technical experts will present at three sessions during the conference: Spotlight Presentation: Controlling Phosphorothioate Stereochemistry: Challenges and Innovations in &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Codexis to share RNA manufacturing advances at TIDES USA&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-956009","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Codexis to share RNA manufacturing advances at TIDES USA - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Codexis to share RNA manufacturing advances at TIDES USA - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) &#8212; Codexis, Inc. (NASDAQ: CDXS) a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, will present new data on ECO Synthesis\u00ae Manufacturing Platform and provide an update on regulatory engagement for its enzymatic platform at TIDES USA, held May 11\u201314 at the Hynes Convention Center in Boston. As RNAi therapies expand into larger indications, manufacturing scalability, maintaining process control and delivering high-quality product is critical. Codexis will present data demonstrating advances in controlling phosphorothioate stereochemistry, improved ligation efficiency and process performance, alongside the sustainability advantages of siRNA manufacturing approaches. Codexis\u2019 technical experts will present at three sessions during the conference: Spotlight Presentation: Controlling Phosphorothioate Stereochemistry: Challenges and Innovations in &hellip; Continue reading &quot;Codexis to share RNA manufacturing advances at TIDES USA&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-29T13:05:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwOTMwMyM3NTcyMzk2IzIwMTY1MzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Codexis to share RNA manufacturing advances at TIDES USA\",\"datePublished\":\"2026-04-29T13:05:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\\\/\"},\"wordCount\":387,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcwOTMwMyM3NTcyMzk2IzIwMTY1MzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\\\/\",\"name\":\"Codexis to share RNA manufacturing advances at TIDES USA - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcwOTMwMyM3NTcyMzk2IzIwMTY1MzQ=\",\"datePublished\":\"2026-04-29T13:05:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcwOTMwMyM3NTcyMzk2IzIwMTY1MzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcwOTMwMyM3NTcyMzk2IzIwMTY1MzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Codexis to share RNA manufacturing advances at TIDES USA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Codexis to share RNA manufacturing advances at TIDES USA - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/","og_locale":"en_US","og_type":"article","og_title":"Codexis to share RNA manufacturing advances at TIDES USA - Market Newsdesk","og_description":"REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) &#8212; Codexis, Inc. (NASDAQ: CDXS) a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, will present new data on ECO Synthesis\u00ae Manufacturing Platform and provide an update on regulatory engagement for its enzymatic platform at TIDES USA, held May 11\u201314 at the Hynes Convention Center in Boston. As RNAi therapies expand into larger indications, manufacturing scalability, maintaining process control and delivering high-quality product is critical. Codexis will present data demonstrating advances in controlling phosphorothioate stereochemistry, improved ligation efficiency and process performance, alongside the sustainability advantages of siRNA manufacturing approaches. Codexis\u2019 technical experts will present at three sessions during the conference: Spotlight Presentation: Controlling Phosphorothioate Stereochemistry: Challenges and Innovations in &hellip; Continue reading \"Codexis to share RNA manufacturing advances at TIDES USA\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-29T13:05:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwOTMwMyM3NTcyMzk2IzIwMTY1MzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Codexis to share RNA manufacturing advances at TIDES USA","datePublished":"2026-04-29T13:05:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/"},"wordCount":387,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwOTMwMyM3NTcyMzk2IzIwMTY1MzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/","name":"Codexis to share RNA manufacturing advances at TIDES USA - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwOTMwMyM3NTcyMzk2IzIwMTY1MzQ=","datePublished":"2026-04-29T13:05:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwOTMwMyM3NTcyMzk2IzIwMTY1MzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwOTMwMyM3NTcyMzk2IzIwMTY1MzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codexis-to-share-rna-manufacturing-advances-at-tides-usa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Codexis to share RNA manufacturing advances at TIDES USA"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/956009","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=956009"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/956009\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=956009"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=956009"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=956009"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}